We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

PLAY:NASDAQDave & Buster's Entertainment, Inc. Analysis

Data as of 2026-05-19 - not real-time

$10.70

Latest Price

8/10Risk

Risk Level: High

Executive Summary

The stock is trading at $10.70, well below its 52‑week high of $35.53. Technicals show the 20‑day SMA ($11.02) sits above the price, while the 200‑day SMA ($17.04) remains far higher, indicating a bearish trend. RSI at 44 suggests neutral momentum, and the MACD histogram is slightly positive but the line is still below the signal, hinting at limited upside. Beta of 2.13 and 30‑day volatility of 66% signal a highly volatile equity. Fundamentals are weak: revenue down 0.9%, negative profit margin, trailing EPS -$1.40 and a forward PE of 113 versus industry average 17. Debt‑to‑equity is astronomically high at ~3900%, and free cash flow is negative. Recent news shows the stock has fallen 11.4% since the last earnings report and underperformed peers, with a Q4 earnings miss and a board transition adding uncertainty.
Liquidity is constrained with decreasing volume and a market cap under $400M. Analyst consensus is a buy, but the target median price of $17.5 implies a 63% upside, which seems optimistic given the fundamentals. Overall, the stock appears overvalued and high‑risk.

Market Outlook

Short Term

< 1 year
Cautious
Model confidence: 7/10

Key Factors

  • Bearish technicals with price below the 20‑day SMA
  • High volatility and beta indicating price swings
  • Recent earnings miss and 11.4% share decline

Medium Term

1–3 years
Neutral
Model confidence: 5/10

Key Factors

  • Analyst target price suggests upside if a turnaround occurs
  • Potential operational improvements from new board direction
  • Continued revenue pressure and high debt load

Long Term

> 3 years
Neutral
Model confidence: 4/10

Key Factors

  • Sustained negative profit margins and weak cash generation
  • Industry cyclicality and discretionary spending risk
  • Elevated leverage limiting strategic flexibility

Key Metrics & Analysis

Financial Health

Revenue Growth-0.90%
Profit Margin-2.32%
P/E Ratio113.3
ROE-41.10%
ROA1.90%
Debt/Equity3909.32
P/B Ratio4.1
Op. Cash Flow$290.8M
Free Cash Flow$-133712496
Industry P/E17.1

Technical Analysis

TrendBearish
RSI44.0
Support$9.70
Resistance$13.16
MA 20$11.02
MA 50$11.99
MA 200$17.04
MACDBullish
VolumeDecreasing
Fear & Greed Index89.14

Valuation

Target Price$18.88
Upside/Downside76.40%
GradeOvervalued
TypeBlend

Risk Assessment

Beta2.13
Volatility66.25%
Sector RiskMedium
Reg. RiskLow
Geo RiskLow
Currency RiskLow
Liquidity RiskHigh

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.